{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:53:43Z","timestamp":1767192823897},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Paratek Pharmaceuticals, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40121-021-00587-4","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T13:02:50Z","timestamp":1641906170000},"page":"517-531","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs"],"prefix":"10.1007","volume":"11","author":[{"given":"Gregory J.","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya","family":"Chitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"587_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid1509.081228","volume":"15","author":"J Edelsberg","year":"2009","unstructured":"Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15:1516\u20138.","journal-title":"Emerg Infect Dis"},{"key":"587_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40121-018-0211-4","volume":"7","author":"GJ Moran","year":"2018","unstructured":"Moran GJ, De Anda C, Das AF, Green S, Mehra P, Prokocimer P. Efficacy and safety of tedizolid and linezolid for the treatment of acute bacterial skin and skin structure infections in injection drug users: analysis of two clinical trials. Infect Dis Ther. 2018;7:509\u201322.","journal-title":"Infect Dis Ther"},{"issue":"Suppl 3","key":"587_CR3","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1093\/cid\/ciz004","volume":"68","author":"Y Golan","year":"2019","unstructured":"Golan Y. Current treatment options for acute skin and skin-structure infections. Clin Infect Dis. 2019;68(Suppl 3):S206\u201312.","journal-title":"Clin Infect Dis"},{"key":"587_CR4","first-page":"143","volume":"4","author":"A Pulido-Cejudo","year":"2017","unstructured":"Pulido-Cejudo A, Guzman-Gutierrez M, Jalife-Montano A, et al. Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis. 2017;4:143\u201361.","journal-title":"Ther Adv Infect Dis"},{"key":"587_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2147\/IDR.S142140","volume":"11","author":"E Righi","year":"2018","unstructured":"Righi E, Carnelutti A, Vena A, Bassetti M. Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin. Infect Drug Resist. 2018;11:479\u201388.","journal-title":"Infect Drug Resist"},{"key":"587_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMoa055356","volume":"355","author":"GJ Moran","year":"2006","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA, EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666\u201374.","journal-title":"N Engl J Med"},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2334-14-296","volume":"14","author":"JA Suaya","year":"2014","unstructured":"Suaya JA, Mera RM, Cassidy A, et al. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis. 2014;14:296.","journal-title":"BMC Infect Dis"},{"key":"587_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1099\/jmm.0.027540-0","volume":"60","author":"KS Kaushik","year":"2011","unstructured":"Kaushik KS, Kapila K, Praharaj AK. Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol. 2011;60:408\u201322.","journal-title":"J Med Microbiol"},{"key":"587_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.01.029","volume":"187","author":"RE Harris","year":"2018","unstructured":"Harris RE, Richardson J, Frasso R, Anderson ED. Experiences with skin and soft tissue infections among people who inject drugs in Philadelphia: a qualitative study. Drug Alcohol Depend. 2018;187:8\u201312.","journal-title":"Drug Alcohol Depend"},{"key":"587_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/320879","volume":"33","author":"EL Murphy","year":"2001","unstructured":"Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35\u201340.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"587_CR11","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1093\/infdis\/jiaa149","volume":"222","author":"I See","year":"2020","unstructured":"See I, Gokhale RH, Geller A, et al. National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review. J Infect Dis. 2020;222(Suppl 5):S429\u201336.","journal-title":"J Infect Dis"},{"key":"587_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/00952991003592311","volume":"36","author":"KT Phillips","year":"2010","unstructured":"Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse. 2010;36:92\u20137.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"587_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/313703","volume":"30","author":"IA Binswanger","year":"2000","unstructured":"Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579\u201381.","journal-title":"Clin Infect Dis"},{"key":"587_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1360-0443.1997.tb02853.x","volume":"92","author":"A Morrison","year":"1997","unstructured":"Morrison A, Elliott L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 1997;92:1349\u201352.","journal-title":"Addiction"},{"key":"587_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/acem.12727","volume":"22","author":"TC Jenkins","year":"2015","unstructured":"Jenkins TC, Knepper BC, Jason Moore S, et al. Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus. Acad Emerg Med. 2015;22:993\u20137.","journal-title":"Acad Emerg Med"},{"issue":"Suppl 2","key":"587_CR16","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1093\/clinids\/20.Supplement_2.S279","volume":"20","author":"PH Summanen","year":"1995","unstructured":"Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20(Suppl 2):S279\u201382.","journal-title":"Clin Infect Dis"},{"key":"587_CR17","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/jac\/dkq355","volume":"65","author":"J Ho","year":"2010","unstructured":"Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrob Chemother. 2010;65:2641\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"587_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11469-014-9511-4","volume":"13","author":"S Jafari","year":"2015","unstructured":"Jafari S, Joe R, Elliot D, Nagji A, Hayden S, Marsh DC. A community care model of intravenous antibiotic therapy for injection drug users with deep tissue infection for \u201cReduce leaving against medical advice.\u201d Int J Ment Health Addict. 2015;13:49\u201358.","journal-title":"Int J Ment Health Addict"},{"key":"587_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2334-8-42","volume":"8","author":"D Mertz","year":"2008","unstructured":"Mertz D, Viktorin N, Wolbers M, et al. Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis. BMC Infect Dis. 2008;8:42.","journal-title":"BMC Infect Dis"},{"key":"587_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1800170","volume":"380","author":"W O'Riordan","year":"2019","unstructured":"O\u2019Riordan W, Green S, Overcash JS, et al. Omadacycline for acute bacterial skin and skin-structure infections. N Engl J Med. 2019;380:528\u201338.","journal-title":"N Engl J Med"},{"key":"587_CR21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(19)30275-0","volume":"19","author":"W O'Riordan","year":"2019","unstructured":"O\u2019Riordan W, Cardenas C, Shin E, et al. Once daily oral omadacycline versus twice daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2019;19:1080\u201390.","journal-title":"Lancet Infect Dis"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/sim.4780040211","volume":"4","author":"O Miettinen","year":"1985","unstructured":"Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213\u201326.","journal-title":"Stat Med"},{"key":"587_CR23","doi-asserted-by":"publisher","first-page":"ofx183","DOI":"10.1093\/ofid\/ofx183","volume":"4","author":"PM Dobson","year":"2017","unstructured":"Dobson PM, Loewenthal MR, Schneider K, Lai K. Comparing injecting drug users with others receiving outpatient parenteral antibiotic therapy. Open Forum Infect Dis. 2017;4:ofx183.","journal-title":"Open Forum Infect Dis"},{"key":"587_CR24","doi-asserted-by":"publisher","first-page":"ofx102","DOI":"10.1093\/ofid\/ofx102","volume":"4","author":"DJ Buehrle","year":"2017","unstructured":"Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. Open Forum Infect Dis. 2017;4:ofx102.","journal-title":"Open Forum Infect Dis"},{"key":"587_CR25","doi-asserted-by":"publisher","first-page":"ofy194","DOI":"10.1093\/ofid\/ofy194","volume":"5","author":"J Suzuki","year":"2018","unstructured":"Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature. Open Forum Infect Dis. 2018;5:ofy194.","journal-title":"Open Forum Infect Dis"},{"key":"587_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/cid\/ciw750","volume":"64","author":"D Nathwani","year":"2017","unstructured":"Nathwani D, Corey R, Das AF, Sandison T, De Anda C, Prokocimer P. Early clinical response as a predictor of late treatment success in patients with acute bacterial skin and skin structure infections: retrospective analysis of 2 randomized controlled trials. Clin Infect Dis. 2017;64:214\u20137.","journal-title":"Clin Infect Dis"},{"key":"587_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/AAC.03688-14","volume":"59","author":"AF Shorr","year":"2015","unstructured":"Shorr AF, Lodise TP, Corey GR, et al. Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrob Agents Chemother. 2015;59:864\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"587_CR28","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.3748\/wjg.v19.i44.7846","volume":"19","author":"M Zeremski","year":"2013","unstructured":"Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol. 2013;19:7846\u201351.","journal-title":"World J Gastroenterol"},{"key":"587_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jurban\/jtg127","volume":"80","author":"TA Takahashi","year":"2003","unstructured":"Takahashi TA, Merrill JO, Boyko EJ, Bradley KA. Type and location of injection drug use-related soft tissue infections predict hospitalization. J Urban Health. 2003;80:127\u201336.","journal-title":"J Urban Health"},{"issue":"Suppl 5","key":"587_CR30","doi-asserted-by":"publisher","first-page":"S494","DOI":"10.1093\/infdis\/jiaa025","volume":"222","author":"CN Price","year":"2020","unstructured":"Price CN, Solomon DA, Johnson JA, Montgomery MW, Martin B, Suzuki J. Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs. J Infect Dis. 2020;222(Suppl 5):S494\u20138.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"587_CR31","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/ciz396","volume":"69","author":"FM Abrahamian","year":"2019","unstructured":"Abrahamian FM, Sakoulas G, Tzanis E, et al. Omadacycline for acute bacterial skin and skin structure infections. Clin Infect Dis. 2019;69(Suppl 1):S23-32.","journal-title":"Clin Infect Dis"},{"key":"587_CR32","first-page":"1181","volume":"52","author":"SC Williams","year":"2017","unstructured":"Williams SC, Davey-Rothwell MA, Tobin KE, Latkin C. People who inject drugs and have mood disorders-a brief assessment of health risk behaviors. Subst Use Misuse. 2017;52:1181\u201390.","journal-title":"Subst Use Misuse"},{"key":"587_CR33","first-page":"6","volume":"6","author":"S Heta","year":"2018","unstructured":"Heta S, Robo I. The side effects of the most commonly used group of antibiotics in periodontal treatments. Med Sci (Basel). 2018;6:6.","journal-title":"Med Sci (Basel)"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00587-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:43:48Z","timestamp":1644947028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00587-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00587-4","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}